Resultados de procura - Matthias D’Huyvetter

  • Mostrando 1 - 16 Resultados de 16
Limitar resultados
  1. 1
    Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer

    Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer por Matthias D’Huyvetter, Catarina Xavier, Vicky Caveliers, Tony Lahoutte, Serge Muyldermans, Nick Devoogdt

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle

    Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle por Yana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, Janik Puttemans, Serge Muyldermans, Tony Lahoutte, Matthias D’Huyvetter, Nick Devoogdt

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology

    Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology por Ahmet Krasniqi, Matthias D’Huyvetter, Nick Devoogdt, Fredrik Y. Frejd, Jens Christian Hedemann Sørensen, Anna Orlova, Marleen Keyaerts, Vladimir Tolmachev

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Theranostics in immuno-oncology using nanobody derivatives

    Theranostics in immuno-oncology using nanobody derivatives por Quentin Lecocq, Yannick De Vlaeminck, Heleen Hanssens, Matthias D’Huyvetter, Geert Raes, Cleo Goyvaerts, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Synthesis, Preclinical Validation, Dosimetry, and Toxicity of <sup>68</sup>Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer

    Synthesis, Preclinical Validation, Dosimetry, and Toxicity of <sup>68</sup>Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer por Catarina Xavier, Ilse Vaneycken, Matthias D’Huyvetter, Johannes Heemskerk, Marleen Keyaerts, Cécile Vincke, Nick Devoogdt, Serge Muyldermans, Tony Lahoutte, Vicky Caveliers

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Targeted Radionuclide Therapy with A <sup>177</sup>Lu-labeled Anti-HER2 Nanobody

    Targeted Radionuclide Therapy with A <sup>177</sup>Lu-labeled Anti-HER2 Nanobody por Matthias D’Huyvetter, Cécile Vincke, Catarina Xavier, An Aerts, Nathalie Impens, Sarah Baatout, Hendrik De Raeve, Serge Muyldermans, Vicky Caveliers, Nick Devoogdt, Tony Lahoutte

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma

    Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma por Ahmet Krasniqi, Matthias D’Huyvetter, Catarina Xavier, Kevin Van der Jeught, Serge Muyldermans, José Van der Heyden, Tony Lahoutte, Jan Tavernier, Nick Devoogdt

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis

    SPECT Imaging of Joint Inflammation with Nanobodies Targeting the Macrophage Mannose Receptor in a Mouse Model for Rheumatoid Arthritis por Stéphanie Put, Steve Schoonooghe, Nick Devoogdt, Evelien Schurgers, Anneleen Avau, Tania Mitera, Matthias D’Huyvetter, Patrick De Baetselier, Geert Raes, Tony Lahoutte, Patrick Matthys

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

    131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment por Matthias D’Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszyński, Yann G.‐J. Sterckx, Sam Massa, Geert Raes, Vicky Caveliers, Michael R. Zalutsky, Tony Lahoutte, Nick Devoogdt

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior por Yana Dekempeneer, Tom Bäck, Emma Aneheim, Holger Jensen, Janik Puttemans, Catarina Xavier, Marleen Keyaerts, Stig Palm, Per Albertsson, Tony Lahoutte, Vicky Caveliers, Sture Lindegren, Matthias D’Huyvetter

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α

    Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α por Yana Dekempeneer, Sam Massa, Francis Santens, Laurent Navarro, Marion Berdal, Melissa Miranda Lucero, Ana Rita Pombo Antunes, Tony Lahoutte, Jo A. Van Ginderachter, Nick Devoogdt, Matthias D’Huyvetter

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours

    Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours por Pieterjan Debie, Chrystel Lafont, Michel Defrise, Inge Hansen, Danny M. van Willigen, Fijs W. B. van Leeuwen, Rik Gijsbers, Matthias D’Huyvetter, Nick Devoogdt, Tony Lahoutte, Patrice Mollard, Sophie Hernot

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

    Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies por Janik Puttemans, Yana Dekempeneer, Jos Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D. Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Aliyah Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt, Matthias D’Huyvetter

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using <sup>18</sup>F-Radiolabeled Camelid Single-Domain Antibody Fragments

    PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using <sup>18</sup>F-Radiolabeled Camelid Single-Domain Antibody Fragments por Anneleen Blykers, Steve Schoonooghe, Catarina Xavier, Kevin D’hoe, Damya Laoui, Matthias D’Huyvetter, Ilse Vaneycken, Frederik Cleeren, Guy Bormans, Johannes Heemskerk, Geert Raes, Patrick De Baetselier, Tony Lahoutte, Nick Devoogdt, Jo A. Van Ginderachter, Vicky Caveliers

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients

    Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients por Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, François P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, Frank van der Aa, N. Harry Hendrikse, Jos Eersels, Hendrik Everaert, Pieterjan Gykiere, Nick Devoogdt, Geert Raes, Tony Lahoutte, Marleen Keyaerts

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Targeted α-Therapy Using<sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

    Targeted α-Therapy Using<sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the... por Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Aliyah Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter, Karine Breckpot

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: